Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of life sciences instrumentation company Bruker
So what: Stop me if you've heard this one: Blame Europe! Due to weakness in European demand -- specifically from European governments that set educational budgets, Bruker's primary customer -- and a weaker euro currency, Bruker now expects to report an adjusted profit in the second quarter of $0.11 to $0.13 on sales of $420 million. Wall Street had been expecting the life sciences tool maker to report a profit of $0.21 on sales of $434 million.
Now what: Today's earnings miss really shouldn't come as a surprise given the weakness in Europe, but definitely the magnitude is higher than anyone had expected. Bruker's rival Waters
Craving more input? Start by adding Bruker to your free and personalized Watchlist so you can keep up on the latest news with the company.
Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.